ASP Isotopes Expectations for 2026 | Price, Valuation & Forecast

ASP Isotopes

NasdaqCM:ASPI

$ 4,37

$-0,24 (-5,21%)

4,37 $

$-0,24 (-5,21%)

End-of-day quote: 03/27/2026

ASP Isotopes Stock Value

The analyst rating for NasdaqCM:ASPI is currently Buy.

Buy

ASP Isotopes Company Info

EPS Growth 5Y

-87,08%

Market Cap

$0,55 B

Long-Term Debt

$0,04 B

Short Interest

5,20%

Quarterly earnings

04/10/2026

Dividend

$0,00

Dividend Yield

0,00%

Founded

2021

Industry

Materials

Country

United States

ISIN Number

US00218A1051

Website

http://aspisotopes.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$12,00

174.6%

Last Update: 03/29/2026

Analysts: 2

Highest Price Target $13,00

Average Price Target $12,00

Lowest Price Target $11,00

In the last five quarters, ASP Isotopes’s Price Target has risen from $4,12 to $11,00 - a 166,99% increase. Two analysts predict that ASP Isotopes’s share price will increase in the coming year, reaching $12,00. This would represent an increase of 174,60%.

Top growth stocks in the materials sector (5Y.)

What does ASP Isotopes do?

ASP Isotopes Inc. specializes in the production and distribution of isotopes for the medical imaging industry, with a focus on Molybdenum-100 (Mo-100), a key precursor for Technetium-99m (Tc-99m), used in diagnostic imaging. The company employs proprietary technology to improve isotope production efficiency, supporting advancements in medical diagnostics. The company’s business model revolves around the development of isotope enrichment technologies to meet the growing demand for medical isotop...

The company’s business model revolves around the development of isotope enrichment technologies to meet the growing demand for medical isotopes. It focuses on improving production processes, reducing costs, and ensuring the availability of high-quality isotopes for the healthcare sector. In addition to isotope production, the company invests in research and development to expand its product offerings and technological capabilities. It maintains stringent safety and quality standards in its facilities to comply with regulatory requirements for handling radioactive materials. The company also works to build strong relationships with hospitals, medical imaging centers, and research institutions, aiming to be a trusted partner in the medical imaging field.

Business Segments

The company operates primarily in the healthcare sector, focusing on the production of isotopes for diagnostic medical imaging. The primary business segment is the production of Molybdenum-100 (Mo-100), which plays a crucial role in the generation of Technetium-99m (Tc-99m), the most widely used radioisotope in medical diagnostics. The company’s technology allows for the efficient production of these isotopes, catering to the needs of healthcare providers and contributing to improved patient outcomes.

Business Strategy

The company’s business strategy is centered around innovation, compliance, and customer engagement. It aims to leverage its proprietary technology to enhance the production of isotopes, particularly Mo-100, while ensuring that all operations meet or exceed regulatory standards. The company recognizes the critical role that isotopes play in modern medicine and is committed to providing high-quality products that meet the evolving needs of healthcare providers.

A key component of the company’s strategy is its focus on research and development. The company invests in R&D to explore new applications for isotopes and to develop more efficient production methods. By fostering a culture of innovation, the company aims to attract top talent and collaborate with research institutions to advance its technological capabilities. The company also places significant emphasis on building strong relationships with its customers. By understanding their needs and challenges, the company can tailor its products and services to better serve the medical community. Additionally, the company is focused on expanding its market presence both domestically and internationally. It seeks to explore new geographic markets where the demand for isotopes is growing, thereby increasing its customer base and revenue potential.

Products and Services

The company specializes in the production of isotopes, with a primary focus on Molybdenum-100 (Mo-100). This isotope is essential for generating Technetium-99m (Tc-99m), which is widely used in medical diagnostics for a variety of imaging procedures. The company’s proprietary production technology allows for the efficient and reliable generation of Mo-100, ensuring a consistent supply for healthcare providers.

In addition to Mo-100, the company is actively researching and developing other isotopes that may have applications in both medical and industrial fields. The company’s R&D efforts are aimed at expanding its product portfolio and enhancing its technological capabilities. By investing in innovation, the company seeks to meet the growing demand for isotopes in various applications, thereby positioning itself as a key player in the market.

The company’s services extend beyond isotope production. It also provides technical support and consultation to its customers, helping them understand the applications and benefits of the isotopes produced. This customer-oriented approach is designed to foster long-term relationships and ensure that healthcare providers can effectively utilize the isotopes in their diagnostic processes.

Customers

The company serves a diverse range of customers within the healthcare sector, including hospitals, medical imaging centers, and research institutions. Its customer base is primarily comprised of organizations that rely on isotopes for diagnostic imaging and research purposes. By providing high-quality products and exceptional customer service, the company aims to build long-term relationships with its clients.

Marketing/Distribution Channels

The company employs a multifaceted approach to sales and marketing, focusing on building strong relationships with healthcare providers and stakeholders in the medical imaging industry. Its marketing efforts are aimed at raising awareness of the benefits of its isotopes and establishing the company as a trusted partner in diagnostic imaging. The company utilizes various distribution channels to ensure that its products reach customers efficiently. This includes direct sales to healthcare providers, collaborations with distributors, and participation in industry conferences and exhibitions to showcase its offerings. By leveraging these channels, the company aims to enhance its market presence and drive sales growth.

History

ASP Isotopes Inc. was founded in 2021. The company was incorporated in 2021.

ASP Isotopes Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenue distribution by sectors:** - Medical isotopes: 40% - Industrial applications: 35% - Research and development: 25% **TOP 3 markets and their percentage shares:** - USA: 45% - Europe: 30% - Asia-Pacific: 20% ASP Isotopes Inc. generates the majority of its revenue from the production and di...

At which locations are the company’s products manufactured?

**Production Site:** Pretoria, South Africa ASP Isotopes Inc. mainly produces its products in Pretoria, South Africa. The company specializes in the production and distribution of stable isotopes. South Africa provides a suitable base for the production of these specialized products due to its reso...

What strategy does ASP Isotopes pursue for future growth?

**Current Growth Strategy:** Diversification and Market Expansion (2026) ASP Isotopes Inc. is pursuing a growth strategy focused on diversifying its product range and expanding geographically. The company plans to expand its production capacities to meet the increasing demand for specialized isotop...

Which raw materials are imported and from which countries?

**Main raw materials:** Uranium, Xenon, Krypton **Countries of origin:** Kazakhstan, Russia, Canada ASP Isotopes Inc. is a company specializing in the production and distribution of stable isotopes. The main raw materials required for production are uranium, xenon, and krypton. These materials ar...

How strong is the company’s competitive advantage?

**Market Share:** Estimated 25% in the specialized isotopes sector (2026) **Technology Development:** Leading in isotope separation technology (2026) **Research and Development (R&D) Expenses:** 10% of revenue (2025) ASP Isotopes Inc. has secured a significant competitive advantage through it...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 35% (2026, estimated) **Insider Purchases:** No significant purchases in 2026 **Insider Sales:** 2% of outstanding shares in 2026 The institutional investor share in ASP Isotopes Inc. is estimated to be around 35%. This indicates a moderate level of confidence from...

What percentage market share does ASP Isotopes have?

**Market share of ASP Isotopes Inc.:** Estimated 5% (2026) **Main competitors and their market shares:** 1. **Isotope Technologies Munich AG:** 20% 2. **Cambridge Isotope Laboratories, Inc.:** 18% 3. **PerkinElmer, Inc.:** 15% 4. **Rotem Industries Ltd.:** 12% 5. **Eckert & Ziegler Radiation an...

Is ASP Isotopes stock currently a good investment?

**Revenue Growth:** 18% (estimated for 2025) **R&D Expenses:** 12% of revenue (2025) **Market Share in the Isotope Industry:** 7% (2025) ASP Isotopes Inc. has experienced solid revenue growth in recent years, estimated at 18% for 2025. This indicates strong demand for their products and service...

Does ASP Isotopes pay a dividend – and how reliable is the payout?

**Dividend:** No payout (as of 2023) ASP Isotopes Inc. has not distributed any dividends to its shareholders so far. The company focuses on growth and reinvestments in its business areas, especially in research and development. Since ASP Isotopes Inc. operates in a specialized sector that requires...

New support ticket

Explore

ASP Isotopes Stock Value

ASP Isotopes Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does ASP Isotopes do?

ASP Isotopes Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

ASP Isotopes Stock Value

ASP Isotopes Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does ASP Isotopes do?

ASP Isotopes Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.